Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan L Longo

Showing results (71-80 of 219) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|December 14, 2021
CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?Mark Roschewski, Dan L Longo, Wyndham H Wilson
JAMA Oncology|February 6, 2025
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma: A Narrative ReviewMark Roschewski, Dan L Longo, James O Armitage
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Improving Prospects for Targeting RASHarshabad Singh, Dan L Longo, Bruce A Chabner
The New England Journal of Medicine|December 12, 2017
A Milestone for CAR T CellsEric Tran, Dan L Longo, Walter J Urba
The Journal of Biological Chemistry|November 13, 2010
Recruitment of RelB to the Csf2 promoter enhances RelA-mediated transcription of granulocyte-macrophage colony-stimulating factorCarl Y Sasaki, Paritosh Ghosh, Dan L Longo
The New England Journal of Medicine|May 30, 2008
Hutchinson-Gilford progeria syndromeWilliam B Ershler, Luigi Ferrucci, Dan L Longo
The New England Journal of Medicine|October 10, 2019
Talking about Toxicity - "What We've Got Here Is a Failure to Communicate"Chana A Sacks, Pamela W Miller, Dan L Longo
Cellular Immunology|February 7, 2006
Dual isotype expressing B cells [kappa(+)/lambda(+)] arise during the ontogeny of B cells in the bone marrow of normal nontransgenic miceLouis J Rezanka, James J Kenny, Dan L Longo
Immunobiology|December 6, 2005
2 BCR or NOT 2 BCR - receptor dilution: a unique mechanism for preventing the development of holes in the protective B cell repertoireLouis J Rezanka, James J Kenny, Dan L Longo
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory SoupEric J Rubin, Dan L Longo, Lindsey R Baden
Pageof 22

Showing results (71-80 of 219) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|December 14, 2021
CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?Mark Roschewski, Dan L Longo, Wyndham H Wilson
JAMA Oncology|February 6, 2025
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma: A Narrative ReviewMark Roschewski, Dan L Longo, James O Armitage
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2015
Improving Prospects for Targeting RASHarshabad Singh, Dan L Longo, Bruce A Chabner
The New England Journal of Medicine|December 12, 2017
A Milestone for CAR T CellsEric Tran, Dan L Longo, Walter J Urba
The Journal of Biological Chemistry|November 13, 2010
Recruitment of RelB to the Csf2 promoter enhances RelA-mediated transcription of granulocyte-macrophage colony-stimulating factorCarl Y Sasaki, Paritosh Ghosh, Dan L Longo
The New England Journal of Medicine|May 30, 2008
Hutchinson-Gilford progeria syndromeWilliam B Ershler, Luigi Ferrucci, Dan L Longo
The New England Journal of Medicine|October 10, 2019
Talking about Toxicity - "What We've Got Here Is a Failure to Communicate"Chana A Sacks, Pamela W Miller, Dan L Longo
Cellular Immunology|February 7, 2006
Dual isotype expressing B cells [kappa(+)/lambda(+)] arise during the ontogeny of B cells in the bone marrow of normal nontransgenic miceLouis J Rezanka, James J Kenny, Dan L Longo
Immunobiology|December 6, 2005
2 BCR or NOT 2 BCR - receptor dilution: a unique mechanism for preventing the development of holes in the protective B cell repertoireLouis J Rezanka, James J Kenny, Dan L Longo
The New England Journal of Medicine|February 25, 2021
Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory SoupEric J Rubin, Dan L Longo, Lindsey R Baden
Pageof 22